Major Depressive Disorder (MDD): Updates from the American Psychiatric Association Annual Meeting (APA) 2017 includes major findings about major depressive disorder from APA 2017, including clinical trial data relevant to both community and health-system practice and recognized barriers to implementing those findings in practice.

After reviewing Major Depressive Disorder (MDD), you will be able to:
• Recall the most impactful findings about Major Depressive Disorder (MDD) from the APA 2017 Annual meeting relating to MDD pathophysiology, progression, & prognosis.
• Describe the most impactful findings about MDD from the APA 2017 Annual meeting relating to using the similarities & differences between MDD & bereavement to inform good clinical care.
• Summarize the most impactful findings about MDD from the APA 2017 Annual meeting relating to old, new, emerging, and potential new targets for treating of MDD and apply them to patient cases.

Target Audience:
Healthcare professionals specializing in family medicine, internal medicine, mental health, neurology and psychiatry, or those who otherwise commonly care for patients with MDD or related psychiatric diseases.

After viewing Osteoporosis Management: Advances in Pharmacotherapy, you will be able to:
• Apply the results of diagnostic imaging and pertinent past medical history to determine a given patient’s diagnosis of osteoporosis or osteopenia
• Describe the criteria for initiation of pharmacotherapy for osteoporosis treatment and prevention
• Identify investigational pharmacotherapeutic treatments for management of osteoporosis, and describe their mechanisms of action and likely place in therapy
• Describe the challenges associated with treating patients with osteoporosis, focus specifically on the risks (e.g., adverse drug reactions, drug interactions, etc.) of the agents used to treat and prevent osteoporosis and apply the information in optimizing patient care

Target Audience:
Endocrinologists, geriatricians, internists; physician assistants, nurse practitioners, nurses, and pharmacists who specialize in those areas of medicine and those who otherwise commonly care for patients with osteoporosis.